1. Uncommon cause of dysphagia: paraneoplastic achalasia.
- Author
-
Nasa M, Bhansali S, Choudhary NS, and Sud R
- Subjects
- Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Deglutition Disorders etiology, Deglutition Disorders pathology, Doxorubicin, Esophageal Achalasia complications, Esophageal Achalasia physiopathology, Esophageal Neoplasms drug therapy, Esophageal Neoplasms physiopathology, Esophagoscopy, Humans, Lymphoma, Non-Hodgkin drug therapy, Lymphoma, Non-Hodgkin physiopathology, Male, Middle Aged, Paraneoplastic Syndromes drug therapy, Paraneoplastic Syndromes physiopathology, Prednisone, Rituximab, Treatment Outcome, Vincristine, Deglutition Disorders diagnosis, Endoscopy, Digestive System, Esophageal Achalasia diagnosis, Esophageal Neoplasms diagnosis, Lymphoma, Non-Hodgkin diagnosis, Paraneoplastic Syndromes diagnosis
- Abstract
Achalasia secondary to underlying neoplasm is a rare entity. Early recognition of secondary achalasia is important as its treatment involves management of underlying malignancy, while treatment of primary achalasia mainly involves lowering the lower oesophageal sphincter pressure with pneumatic dilatation or Heller's myotomy. We discuss an interesting case of achalasia secondary to non-Hodgkin's lymphoma., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
- Published
- 2018
- Full Text
- View/download PDF